CYTOGENETIC ABNORMALITY side effect
What is CYTOGENETIC ABNORMALITY ?Drugs associated with CYTOGENETIC ABNORMALITY
AVONEX CYCLOPHOSPHAMIDE CYCLOSPORINE FLUDARABINE GLEEVEC GONAL IMATINIB PREDNISONE REBIF REVLIMID SANDIMMUNE SERTRALINE TRETINOIN VALPROIC VINCRISTINE ZYPREXACYTOGENETIC ABNORMALITY : Valproic Side Effects Report #5675027-2
Consumer or non-health professional from UNITED STATES reported VALPROIC ACID problem on Mar 12, 2008. Female patient, child 2 years of age, was diagnosed with petit mal epilepsy and was treated with VALPROIC ACID. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, leukaemoid reaction, . VALPROIC ACID dosage: 675 MG/DAY (33 MG/KG/DAY. During the same period patient was treated with ZONISAMIDE. Patient was hospitalized. Patient recovered.
CYTOGENETIC ABNORMALITY : Fludarabine Side Effects Report #5625515-X
FLUDARABINE problem was reported by a Physician from UNITED STATES on Feb 11, 2008. Male patient, 55 years of age, was diagnosed with non-hodgkin's lymphoma and was treated with FLUDARABINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, . FLUDARABINE dosage: 250MG/M2 DAY1-3 Q-28D. During the same period patient was treated with MITOXANTRONE, ZEVALIN. Patient recovered.
CYTOGENETIC ABNORMALITY : Revlimid Side Effects Report #5635780-0
Health Professional from FRANCE reported REVLIMID problem on Feb 13, 2008. Female patient, 50 years of age, was diagnosed with myelodysplastic syndrome and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, lung infection, . REVLIMID dosage: 5 MG, DAILY; ORAL, 10 MG, DAILY X3 WEEKS EVERY MONTH; ORAL. Patient died on 12/01/2006.
CYTOGENETIC ABNORMALITY : Vincristine Side Effects Report #5608506-4
VINCRISTINE problem was reported by a Physician from GERMANY on Jan 16, 2008. Male patient, 52 years of age, was diagnosed with lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, . VINCRISTINE dosage: unknown. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE. Patient recovered.
CYTOGENETIC ABNORMALITY : Vincristine Side Effects Report #5608507-6
Physician from GERMANY reported VINCRISTINE problem on Jan 16, 2008. Male patient, 47 years of age, was diagnosed with diffuse large b-cell lymphoma stage iii and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, . VINCRISTINE dosage: unknown. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE. Patient recovered.
CYTOGENETIC ABNORMALITY : Vincristine Side Effects Report #5608509-X
VINCRISTINE problem was reported by a Physician from GERMANY on Jan 16, 2008. Male patient, 54 years of age, was diagnosed with non-hodgkin's lymphoma stage iii and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, . VINCRISTINE dosage: unknown. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE. Patient recovered.
CYTOGENETIC ABNORMALITY : Vincristine Side Effects Report #5608515-5
Physician from GERMANY reported VINCRISTINE problem on Jan 16, 2008. Male patient, 56 years of age, was diagnosed with b-cell lymphoma stage iv, b-lymphocyte count increased and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, granulocytes abnormal, haematopoietic stem cell mobilisation, . VINCRISTINE dosage: unknown. During the same period patient was treated with DOXORUBICIN. Patient recovered.
CYTOGENETIC ABNORMALITY : Vincristine Side Effects Report #5608528-3
VINCRISTINE problem was reported by a Physician from GERMANY on Jan 16, 2008. Male patient, 48 years of age, was diagnosed with lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, . VINCRISTINE dosage: unknown. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE. Patient recovered.
CYTOGENETIC ABNORMALITY : Vincristine Side Effects Report #5608529-5
Physician from GERMANY reported VINCRISTINE problem on Jan 16, 2008. Female patient, 47 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with VINCRISTINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, . VINCRISTINE dosage: unknown. During the same period patient was treated with DOXORUBICIN, ETOPOSIDE. Patient recovered.
CYTOGENETIC ABNORMALITY : Rebif Side Effects Report #5481987-5
REBIF problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 24, 2007. Female patient was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, . REBIF dosage: unknown. Patient died.
CYTOGENETIC ABNORMALITY : Zyprexa Side Effects Report #5406822-2
Physician from AUSTRALIA reported ZYPREXA problem on July 24, 2007. Female patient, weighting 0.68 lb, was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, failure to thrive, . ZYPREXA dosage: 5 MG, DAILY (1/D). During the same period patient was treated with ELEVIT, TEMAZE. Patient recovered.
CYTOGENETIC ABNORMALITY : Cyclophosphamide Side Effects Report #5400582-7
CYCLOPHOSPHAMIDE problem was reported by a Health Professional from UNITED STATES on July 24, 2007. Male patient, 55 years of age, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, myelodysplastic syndrome, refractory anaemia, . CYCLOPHOSPHAMIDE dosage: unknown. Patient recovered.
CYTOGENETIC ABNORMALITY : Cyclophosphamide Side Effects Report #5400582-7
Health Professional from UNITED STATES reported CYCLOPHOSPHAMIDE problem on July 24, 2007. Male patient, 55 years of age, was treated with CYCLOPHOSPHAMIDE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, myelodysplastic syndrome, refractory anaemia, . CYCLOPHOSPHAMIDE dosage: unknown. Patient recovered.
CYTOGENETIC ABNORMALITY : Gleevec Side Effects Report #5648468-7
GLEEVEC problem was reported by a Health Professional from KUWAIT on Feb 22, 2008. Male patient, 43 years of age, was diagnosed with chronic myeloid leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: acute lymphocytic leukaemia, cytogenetic abnormality, . GLEEVEC dosage: 200 MG/D. Patient recovered.
CYTOGENETIC ABNORMALITY : Gleevec Side Effects Report #5688671-3
Consumer or non-health professional from JAPAN reported GLEEVEC problem on Mar 27, 2008. Female patient, 69 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with GLEEVEC. After drug was administered, patient experienced the following problems/side effects: acute lymphocytic leukaemia recurrent, cytogenetic abnormality, lymphadenopathy, multi-organ failure, nausea, platelet count decreased, stem cell transplant, transplant rejection, . GLEEVEC dosage: unknown. Patient was hospitalized. Patient died.
CYTOGENETIC ABNORMALITY : Tretinoin Side Effects Report #5565296-1
TRETINOIN problem was reported by a Physician from AUSTRALIA on Sept 26, 2002. Male patient, 58 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with TRETINOIN. After drug was administered, patient experienced the following problems/side effects: complications of transplant surgery, cytogenetic abnormality, . TRETINOIN dosage: unknown. During the same period patient was treated with CYTOSINE ARABINOSIDE, CYTOSINE ARABINOSIDE, CYTOSINE ARABINOSIDE, IDARUBICIN. Patient died.
CYTOGENETIC ABNORMALITY : Fludarabine Side Effects Report #5533475-5
Consumer or non-health professional from UNITED STATES reported FLUDARABINE PHOSPHATE problem on Nov 14, 2007. Female patient, 49 years of age, was diagnosed with b-cell small lymphocytic lymphoma and was treated with FLUDARABINE PHOSPHATE. After drug was administered, patient experienced the following problems/side effects: acute myeloid leukaemia, cytogenetic abnormality, haemoglobin decreased, platelet count decreased, stem cell transplant, white blood cell count decreased, . FLUDARABINE PHOSPHATE dosage: unknown. During the same period patient was treated with RITUXIMAB. Patient recovered.
CYTOGENETIC ABNORMALITY : Imatinib Side Effects Report #5477895-6
IMATINIB problem was reported by a Health Professional from CANADA on Sept 28, 2007. Male patient was diagnosed with chronic myeloid leukaemia and was treated with IMATINIB. After drug was administered, patient experienced the following problems/side effects: anaemia, cytogenetic abnormality, myelodysplastic syndrome, perianal abscess, . IMATINIB dosage: 400 MG/D. During the same period patient was treated with HYDROXYUREA. Patient recovered.
CYTOGENETIC ABNORMALITY : Zyprexa Side Effects Report #5479177-5
Physician from AUSTRALIA reported ZYPREXA problem on Oct 04, 2007. Female patient was diagnosed with bipolar disorder and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: acidosis, cytogenetic abnormality, foetal growth retardation, gastrooesophageal reflux disease, haemoglobin decreased, . ZYPREXA dosage: 5 MG, DAILY (1/D). During the same period patient was treated with ELEVIT, TEMAZE. Patient recovered.
CYTOGENETIC ABNORMALITY : Sertraline Side Effects Report #5481106-5
SERTRALINE problem was reported by a Consumer or non-health professional from SWITZERLAND on Dec 11, 2006. Female patient, 14 years of age, was diagnosed with obsessive-compulsive disorder and was treated with SERTRALINE. After drug was administered, patient experienced the following problems/side effects: cytogenetic abnormality, grand mal convulsion, loss of consciousness, . SERTRALINE dosage: 25,000 MG (25 MG, 1 IN 1 D); 200,000 MG (200 MG, 1 IN 1 D); 62,000 MG (62 MG, 1 IN 1 D). During the same period patient was treated with OLANZAPINE, LORAZEPAM. Patient was hospitalized. Patient recovered.
CYTOGENETIC ABNORMALITY : Zyprexa Side Effects Report #5460568-3
Physician from AUSTRALIA reported ZYPREXA problem on Sept 06, 2007. Female patient was diagnosed with bipolar disorder and was treated with ZYPREXA. After drug was administered, patient experienced the following problems/side effects: acidosis, cytogenetic abnormality, foetal growth retardation, gastrooesophageal reflux disease, haemoglobin decreased, . ZYPREXA dosage: 5 MG, DAILY (1/D). During the same period patient was treated with ELEVIT, TEMAZE. Patient recovered.
CYTOGENETIC ABNORMALITY : Gonal Side Effects Report #5472207-6
GONAL problem was reported by a Physician from UNITED STATES on Sept 12, 2007. Female patient, 35 years of age, was diagnosed with infertility and was treated with GONAL. After drug was administered, patient experienced the following problems/side effects: abortion missed, cytogenetic abnormality, pregnancy, . GONAL dosage: unknown. Patient recovered.
CYTOGENETIC ABNORMALITY : Avonex Side Effects Report #5408254-X
Consumer or non-health professional from GERMANY reported AVONEX problem on July 20, 2007. Female patient, 29 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, cytogenetic abnormality, multiple sclerosis, pregnancy, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.
CYTOGENETIC ABNORMALITY : Gonal Side Effects Report #5412065-9
GONAL problem was reported by a Consumer or non-health professional from UNITED STATES on July 31, 2007. Female patient, 37 years of age, was diagnosed with infertility and was treated with GONAL. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, cytogenetic abnormality, pregnancy, . GONAL dosage: unknown. Patient recovered.
CYTOGENETIC ABNORMALITY : Sandimmune Side Effects Report #5419030-6
Consumer or non-health professional from JAPAN reported SANDIMMUNE problem on Aug 10, 2007. Male patient, child 11 years of age, was diagnosed with focal glomerulosclerosis and was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, cytogenetic abnormality, disease progression, focal glomerulosclerosis, nasopharyngitis, nephropathy, oedema, renal failure chronic, tubulointerstitial nephritis, . SANDIMMUNE dosage: 75 MG/DAY. During the same period patient was treated with NEORAL. Patient recovered.
CYTOGENETIC ABNORMALITY : Sandimmune Side Effects Report #5419031-8
SANDIMMUNE problem was reported by a Consumer or non-health professional from JAPAN on Aug 10, 2007. Male patient, child 11 years of age, was diagnosed with focal glomerulosclerosis and was treated with SANDIMMUNE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, cytogenetic abnormality, disease progression, focal glomerulosclerosis, nasopharyngitis, nephropathy, oedema, renal failure chronic, tubulointerstitial nephritis, . SANDIMMUNE dosage: 75 MG/DAY. During the same period patient was treated with NEORAL. Patient recovered.
CYTOGENETIC ABNORMALITY : Cyclosporine Side Effects Report #5388926-6
Consumer or non-health professional from JAPAN reported CYCLOSPORINE problem on July 06, 2007. Male patient, child 11 years of age, was diagnosed with nephrotic syndrome and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, cytogenetic abnormality, focal glomerulosclerosis, nasopharyngitis, nephropathy, oedema, tubulointerstitial nephritis, . CYCLOSPORINE dosage: unknown. Patient recovered.
CYTOGENETIC ABNORMALITY : Prednisone Side Effects Report #5393123-4
PREDNISONE problem was reported by a Health Professional from UNITED STATES on July 12, 2007. Female patient, 59 years of age, was treated with PREDNISONE. After drug was administered, patient experienced the following problems/side effects: chronic myelomonocytic leukaemia, cytogenetic abnormality, . PREDNISONE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.
CYTOGENETIC ABNORMALITY : Cyclosporine Side Effects Report #5388926-6
Consumer or non-health professional from JAPAN reported CYCLOSPORINE problem on July 06, 2007. Male patient, child 11 years of age, was diagnosed with nephrotic syndrome and was treated with CYCLOSPORINE. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, cytogenetic abnormality, focal glomerulosclerosis, nasopharyngitis, nephropathy, oedema, tubulointerstitial nephritis, . CYCLOSPORINE dosage: unknown. Patient recovered.
CYTOGENETIC ABNORMALITY : Prednisone Side Effects Report #5393123-4
PREDNISONE problem was reported by a Health Professional from UNITED STATES on July 12, 2007. Female patient, 59 years of age, was treated with PREDNISONE. After drug was administered, patient experienced the following problems/side effects: chronic myelomonocytic leukaemia, cytogenetic abnormality, . PREDNISONE dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient recovered.